{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:38:49Z","timestamp":1758587929477,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015388","name":"Universit\u00e9 de Tunis El Manar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.therap.2021.12.009","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T21:05:53Z","timestamp":1639602353000},"page":"461-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is there a ceiling lamotrigine serum level in epileptic children in remission?"],"prefix":"10.1016","volume":"77","author":[{"given":"Rim","family":"Charfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emna","family":"Gaies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Ben Sassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanene","family":"El Jebari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Kammoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israa","family":"Dahmene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Jebabli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issam","family":"Salouage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riadh","family":"Daghfous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2021.12.009_bib0065","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"42","author":"Kwan","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.therap.2021.12.009_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yebeh.2017.03.031","article-title":"Lamotrigine serum levels: Ceiling effect in people with epilepsy in remission?","volume":"74","author":"D\u2019Anto","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.therap.2021.12.009_bib0075","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.therap.2021.12.009_bib0080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1528-1167.2011.03355.x","article-title":"Revising the \u201crule of three\u201d for inferring seizure freedom","volume":"53","author":"Westover","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.therap.2021.12.009_bib0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2021.12.009_bib0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1535-7511.2005.05303.x","article-title":"Making sense of lamotrigine serum levels","volume":"5","author":"Abou-Khalil","year":"2005","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.therap.2021.12.009_bib0095","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.therap.2021.12.009_bib0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5603\/PJNNS.a2020.0059","article-title":"Predictors of remission in patients with epilepsy","volume":"54","author":"W\u0119\u017cyk","year":"2020","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.therap.2021.12.009_bib0105","first-page":"65","article-title":"Rational combinations of antiepileptic drugs for refractory epilepsy","volume":"31","author":"Yoshino","year":"2011","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"10.1016\/j.therap.2021.12.009_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.seizure.2018.07.011","article-title":"Evaluation of long-term antiepileptic drug use in patients with temporal lobe epilepsy: Assessment of risk factors for drug resistance and polypharmacy","volume":"61","author":"Bj\u00f8rke","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.therap.2021.12.009_bib0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/ern.09.136","article-title":"Drug interactions involving the new second- and third-generation antiepileptic drugs","volume":"10","author":"Johannessen Landmark","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.therap.2021.12.009_bib0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1684\/j.1950-6945.2002.tb00436.x","article-title":"Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels","volume":"4","author":"Fr\u00f6scher","year":"2002","journal-title":"Epileptic Disord"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721002614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721002614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:54:59Z","timestamp":1758567299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595721002614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0040595721002614"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2021.12.009","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a ceiling lamotrigine serum level in epileptic children in remission?","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2021.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}